soul trial oral semaglutide cardiovascular outcomes results 2024 2025 (NEJM 2025): led to a 14% ↓ in major CV events vs placebo in T2DM with ASCVD or CKD — no ↑ in serious AEs. #Semaglutide #CardioDiabetes #updatesinmedicine 🔴Cardiovascular outcomes with semaglutide by

(April 8, 2025) As glucagon-like peptide 1 (GLP-1) prescription medications commonly used for diabetes management and weight loss continue to increase in popularity, some findings reveal side effects that could affect oral health

If you have questions about Ozempic interactions or medication management, speaking with a licensed provider is always the right next step

[DOI] [PubMed] [Google Scholar] Karthikeyan K, Bai BR, Devaraj SN

Support Your Health While on GLP-1 Medications Our comprehensive GLP-1 Weight Management Support Protocol is specifically chosen for those using weight loss medications

Glutathione is a tripeptidea small molecule made from three amino acids: cysteine, glutamine, and glycine

However, using GLP-1 agonists for minor weight loss or body sculpting when one is already at a healthy weight is not only medically inappropriate but also carries significant health risks without the offsetting medical benefits